BACKGROUND/ PURPOSE: The diagnosis of patients with pulmonary infiltrates and human immunodeficiency virus (HIV) infection remains a challenge. In current clinical practice the gold standard for Pneumocystis jirovecii pneumonia (PCP) diagnosis remains the identification of the organism in bronco alveolar lavage (BAL) using microscopy (e.g., silver stain). (1->3)-β -d-glucan (BG) is a polysaccharide that is present within the cell wall of Pneumocystis and other fungi. METHODS: We analyzed serum and BAL lavage fluid from a cohort of 119 patients that did have HIV, a diagnosis of pneumonia and underwent bronchoscopy (FOB) for diagnosis of PCP. RESULTS: The discriminative power of serum BG for the diagnosis of PCP in this group of patients was very high. Using a cutoff of 300 pg/mL, the sensitivity, specificity, positive predictive value(PPV) and negative predictive value (NPV) were 91%, 92%, 89% and 93% respectively. A model for ROC with just serum BG (N = 108) had an AUC of 0.95. Serum procalcitonin (PCT) and BAL BG were not as accurate for the diagnosis of PCP. For BAL BG using a cutoff of 783 pg/mL, the sensitivity,specificity, positive predictive value (PPV) and negative predictive value (NPV) were 72%, 79%,72% and 79% respectively. The differences between the medians for serum PCT between the group with a without PCP did not reach statistical significance (p = 0.6137). CONCLUSION: The measurement of serum BG should be incorporated in the diagnostic work up of HIV positive patients with dyspnea and infiltrates on chest X X-ray. Our study confirms the diagnostic value of serum BG previously reported by others but we add a cutoff value that we believe is more accurate for patients with AIDS and suspicion of PCP.
BACKGROUND/ PURPOSE: The diagnosis of patients with pulmonary infiltrates and human immunodeficiency virus (HIV) infection remains a challenge. In current clinical practice the gold standard for Pneumocystis jirovecii pneumonia (PCP) diagnosis remains the identification of the organism in bronco alveolar lavage (BAL) using microscopy (e.g., silver stain). (1->3)-β -d-glucan (BG) is a polysaccharide that is present within the cell wall of Pneumocystis and other fungi. METHODS: We analyzed serum and BAL lavage fluid from a cohort of 119 patients that did have HIV, a diagnosis of pneumonia and underwent bronchoscopy (FOB) for diagnosis of PCP. RESULTS: The discriminative power of serum BG for the diagnosis of PCP in this group of patients was very high. Using a cutoff of 300 pg/mL, the sensitivity, specificity, positive predictive value(PPV) and negative predictive value (NPV) were 91%, 92%, 89% and 93% respectively. A model for ROC with just serum BG (N = 108) had an AUC of 0.95. Serum procalcitonin (PCT) and BAL BG were not as accurate for the diagnosis of PCP. For BAL BG using a cutoff of 783 pg/mL, the sensitivity,specificity, positive predictive value (PPV) and negative predictive value (NPV) were 72%, 79%,72% and 79% respectively. The differences between the medians for serum PCT between the group with a without PCP did not reach statistical significance (p = 0.6137). CONCLUSION: The measurement of serum BG should be incorporated in the diagnostic work up of HIV positive patients with dyspnea and infiltrates on chest X X-ray. Our study confirms the diagnostic value of serum BG previously reported by others but we add a cutoff value that we believe is more accurate for patients with AIDS and suspicion of PCP.
Authors: M Ugajin; S Miwa; M Shirai; H Ohba; T Eifuku; H Nakamura; T Suda; H Hayakawa; K Chida Journal: Eur Respir J Date: 2010-06-07 Impact factor: 16.671
Authors: Mark G J de Boer; Luc B S Gelinck; Bertrand D van Zelst; Wendy W J van de Sande; Luuk N A Willems; Jaap T van Dissel; Robert de Jonge; Frank P Kroon Journal: J Infect Date: 2010-10-21 Impact factor: 6.072
Authors: Vicente Friaza; Carmen de la Horra; Mario J Rodríguez-Domínguez; José Martín-Juan; Rafael Cantón; Enrique J Calderón; Rosa Del Campo Journal: J Microbiol Methods Date: 2010-04-09 Impact factor: 2.363
Authors: Stefanie Desmet; Eric Van Wijngaerden; Johan Maertens; Jan Verhaegen; Eric Verbeken; Paul De Munter; Wouter Meersseman; Britt Van Meensel; Johan Van Eldere; Katrien Lagrou Journal: J Clin Microbiol Date: 2009-10-21 Impact factor: 5.948
Authors: S Zeglen; J Wojarski; E Wozniak-Grygiel; M Siola; M Szewczyk; E Kucewicz-Czech; J Nozynski; M Zembala Journal: Transplant Proc Date: 2009-10 Impact factor: 1.066
Authors: Sejal Morjaria; John Frame; Alexandra Franco-Garcia; Alexander Geyer; Mini Kamboj; N Esther Babady Journal: Clin Infect Dis Date: 2019-09-27 Impact factor: 9.079
Authors: Daniel J Lachant; Daniel P Croft; Heather McGrane Minton; Dwight J Hardy; Paritosh Prasad; R Matthew Kottmann Journal: Respir Med Date: 2018-10-22 Impact factor: 3.415